发明名称 Immunogenic Compositions
摘要 The present invention provides compositions comprising a Chlamydial major outer membrane protein (referenced herein as “MOMP”), from at least one Chlamydial serovar and an adjuvant, characterized in that the adjuvant comprises the product E6020 having CAS Number 287180-63-6. The composition may further comprise at least one carrier system (e.g., emulsion, mineral particle). The MOMP protein may be derived from any species of Chlamydia (e.g., C. trachomatis, C. pneumoniae, C. psittaci, or C. trachomatis MoPn). In preferred embodiments, the composition comprises one or more major outer membrane proteins each derived from different serovars of C. trachomatis. The invention also provides methods of inducing an immune response to a Chlamydia species (e.g., C. trachomatis) in a subject, by administering to the subject a composition of the invention.
申请公布号 US2016367655(A1) 申请公布日期 2016.12.22
申请号 US201615075279 申请日期 2016.03.21
申请人 Sanofi Pasteur Limited ;Sanofi Pasteur, S.A. 发明人 Gallichan Scott;Mancevski Ausra;Reveneau Nathalie;Su Jin;Dalencon Francois;Haensler Jean
分类号 A61K39/118;A61K39/39 主分类号 A61K39/118
代理机构 代理人
主权项 1. An immunogenic composition comprising a Chlamydial major outer membrane protein, or an immunogenic fragment thereof, from at least one Chlamydial serovar and an adjuvant, characterized in that the adjuvant comprises at least the product E6020 having CAS Registry Number 287180-63-6.
地址 Toronto CA